Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Christopher M Counter
Introduction
Christopher M Counter is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of cancer research, particularly in the detection of hematological and colorectal malignancies. His innovative approach has the potential to improve diagnostic methods and patient outcomes.
Latest Patents
Christopher M Counter holds a patent for his work titled "Telomerase activity associated with hematological and colorectal malignancies." This patent outlines methods for detecting cancer cells by analyzing samples for telomerase activity. The process involves collecting a sample suspected of containing cancer cells, analyzing it for telomerase activity, and correlating the presence of this activity with the presence of cancer cells. Additionally, his patent provides a method for staging leukemia by analyzing blood or bone marrow samples for telomerase activity and correlating the results with standard levels of activity.
Career Highlights
Christopher is affiliated with McMaster University, where he conducts research and contributes to advancements in medical science. His work has garnered attention for its innovative approach to cancer detection and staging, showcasing his commitment to improving healthcare.
Collaborations
He has collaborated with esteemed colleagues such as Silvia Bacchetti and Brian Leber, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Christopher M Counter's contributions to cancer research through his innovative patent demonstrate his dedication to advancing medical science. His work not only aids in the detection of malignancies but also paves the way for improved diagnostic methods in the future.